ICH Q2
The International Conference on Harmonisation (ICH) is an expert working group with representation from the United States, European and Japanese Pharmacopoeias.
In their harmonized tripartite guideline ICH Q2, Validation of Analytical Procedures: Text and Methodology, they outline characteristics to consider during validation of the four most common types of analytical procedures:
- Identification tests
- Quantitative tests for impurity content
- Limit tests for the control of impurities
- Quantitative tests of the active moiety in samples of a drug substance/product or other selected component(s) in a drug product
ICH Q2 differentiates between validation characteristics required for analyzers used for limit testing of impurities and those used for quantitative analysis of impurities.
Typical validation characteristics include:
|
|
|
The final draft of ICH Q2 is recommended for adoption to the regulatory bodies of the European Union, Japan and the USA.
Webinar
Helpful Links
-
行业标准与法规要求
- USP<643>
- IVDR 2022 is a marathon, not a sprint. We’ll help you go the distance.
- 21 CFR Part 11 - Data Integrity
- Maintaining Data Integrity: Understanding FDA ALCOA Guidance
- European Pharmacopoeia EP 2.2.44
- EU GMP Annex 1
- EU GMP Annex 11
- ICH Q2
- ISO 21501
- ISO Regulations
-
IVD-Regulation (IVDR)
- IVDR compliant software*
- Building IVDR compliant panels for haematological disorders
- Laboratory Developed Test (LDT) vs IVD Validation Workflow
- Potential Impacts of EU IVD-Regulation on the Clinical Flow Cytometry Lab
- Key Considerations to Validate a Flow Cytometry Assay According to ISO 15189 Requirements
- Regulatory Entities: Separation with Cooperation
- USP 1046
- USP 1047
- USP <645>
- USP <788>, <787> and EP2.9.19
- USP <790>
- ISO 11171
- ISO 14644-1
- USP 787